Sr. Director, Global Public Affairs & Policy
Genmab
About this role
The Senior Director, Global Public Affairs & Policy at Genmab is a senior leadership role focused on shaping the company’s global policy and external engagement agenda across Europe and international markets to support timely and sustainable patient access to oncology and hematology therapies. The role bridges policy, science, and commercial priorities to enhance Genmab’s external reputation and strategic positioning.
Skills
Qualifications
About Genmab
genmab.comGenmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
Recent company news
MarketBeatFirst Trust Advisors LP Sells 82,922 Shares of Genmab A/S Sponsored ADR $GMAB
11 hours ago
MorningstarNarrow-Moat Genmab's Royalty Revenue Maintains Near-Term Growth as Pipeline Advancement Progresses
3 days ago
GlobeNewswireTransactions in Connection with Share Buy-back Program
3 days ago
TipRanksGenmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
3 days ago
Yahoo FinanceGenmab Publishes 2025 Annual Report
3 weeks ago
About Genmab
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Genmab.
Salary
$175k – $233k
per year
More jobs at Genmab
Similar Jobs
Director, Global Government Affairs and Public Policy – Europe
ServiceNow
Director Public Policy & Government Affairs
Delivery Hero
Federal Public Policy and Government Affairs Manager
Equinix
Senior Director, European Government Affairs and Public Policy - Europe
BeOne Medicines
Global Medical Affairs Leader, Hematology
AstraZeneca
Policy Affairs Manager/ Value Manager (m/w/d) Schwerpunkt Onkologie und Hämatologie
AstraZeneca